Serum Nardilysin, a Surrogate Marker for Epithelial–Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection

Tomoaki Yoh(Kyoto University), Eiichiro Nishi(Shiga University of Medical Science), Mikiko Ohno(Shiga University of Medical Science), Keiko Iwaisako(University of California San Diego), Hideaki Sueoka(Hyogo Medical University), Kojiro Taura(Kyoto University), Rina Yamaguchi(Kyoto Pharmaceutical Industries (Japan)), Etsuro Hatano(Kyoto University), Yosuke Kasai(Kyoto University), Kiyoto Nishi(Kyoto University), Shinji Üemoto(Shiga University of Medical Science), Satoru Seo(Kōchi University), Takeshi Kimura(Municipal Hirakata City Hospital), Masato Kurokawa(Kyoto Pharmaceutical Industries (Japan)), Jiro Fujimoto(Harvard University), Hiroaki Fuji(Yokohama City University), Kan Toriguchi(Hyogo Medical University)
Clinical Cancer Research
October 23, 2018
10.1158/1078-0432.ccr-18-0124
Cited by 16

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|830
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Identification of Small Molecule Activators of Cryptochrome
|Science|2012|504
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480